Clinical Trials Sponsored by Spruce Biosciences

Total 2000 results

CeloNova BioSciences, Inc.

Completed

The ATLANTA First in Man Study of the Catania Stent (ATLANTA)

Coronary Artery Disease

Italy
Ardea Biosciences, Inc.

Completed

Mild, Moderate and Severe Renal Impairment Study

Gout

United States
Avelas Biosciences, Inc.

Completed

Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery

Breast Cancer

United States
Nanospectra Biosciences, Inc.

Completed

Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck

Head and Neck Cancer

United States
Selecta Biosciences, Inc.

Completed

Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels

Gout

United States
Ardea Biosciences, Inc.

Completed

DECT Study in Allopurinol-Treated Gout Patients

Gout

United States, New Zealand
Ardea Biosciences, Inc.

Completed

Lesinurad and Allopurinol Combination Extension Study in Gout

Gout

United States, South Africa, Spain, Belgium, Australia, Germany, Canada, New Zealand, Poland, Ukraine, Switzerland
Coherus Biosciences, Inc.

Completed

Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta

Healthy

United States
Chipscreen Biosciences, Ltd.

Completed

Phase I Study of Chiauranib in Patients With Advanced Solid Tumors

Solid Tumors

China
Ardea Biosciences, Inc.

Completed

Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat (CRYSTAL)

Tophaceous Gout

Poland, United States, Canada, Australia, New Zealand, Switzerland
Ardea Biosciences, Inc.

Completed

Open-Label Lesinurad Monotherapy Extension Study in Gout

Gout

United States, Canada, Belgium, Australia, Germany, New Zealand, South Africa
Ardea Biosciences, Inc.

Completed

Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors (LIGHT)

Gout

United States, Canada, South Africa, New Zealand, Belgium, Australia, Germany
Chipscreen Biosciences, Ltd.

Completed

Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer

Non-small-cell Lung Cancer

China
Selecta Biosciences, Inc.

Completed

Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers

Smoking Cessation

Belgium
Coherus Biosciences, Inc.

Completed

Assessing the Immunogenicity of 2 Subcutaneous Doses of CHS-1701 (Coherus Pegfilgrastim) With 2 Subcutaneous Doses Neulasta®

Immunity, Humoral

United States
Coherus Biosciences, Inc.

Completed

Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® (Pegfilgrastim)

Bioequivalence

United States
Coronado Biosciences, Inc.

Withdrawn

TSO for Plaque Psoriasis

Plaque Psoriasis
LegoChem Biosciences, Inc

Completed

Multiple Ascending Dose Study for LCB01-0371

Healthy

Korea, Republic of
Biogen
Crescendo Biosciences

Completed

Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients (BATTER-UP)

Arthritis, Rheumatoid

United States
Ardea Biosciences, Inc.

Completed

Bioavailability of Lesinurad and Intravenous [14C]Lesinurad

Healthy

United States
Ardea Biosciences, Inc.

Completed

Antacid Interaction Study

Healthy

United States
Aptose Biosciences Inc.

Completed

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours

Advanced or Metastatic Solid Tumours

United States
Cellectar Biosciences, Inc.

Withdrawn

Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma

Glioma

United States
Ardea Biosciences, Inc.

Completed

Metformin and Furosemide Drug-Drug Interaction Study

Healthy

United States
Ardea Biosciences, Inc.

Completed

Single and Multiple Dose Study in Japanese Subjects

Gout

United States
GenomeDx Biosciences Corp

Completed

Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations (DECIDE)

Prostate Cancer

United States
Ardea Biosciences, Inc.

Completed

Single and Multiple Dose Study in Japanese

Gout

United States
Coronado Biosciences, Inc.

Completed

Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease

Crohn's Disease

United States
Lux Biosciences, Inc.

Completed

A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis (LUMINATE)

Uveitis, Anterior | Panuveitis

United Kingdom, Canada, United States, Germany, Austria, France, India
Lux Biosciences, Inc.

Completed

A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)

Keratoconjunctivitis Sicca

United States
Lux Biosciences, Inc.

Completed

A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis (LUMINATE)

Panuveitis | Uveitis, Posterior | Uveitis, Intermediate

United States, United Kingdom, Canada, Germany, Austria, France, India
FerroKin BioSciences, Inc.

Completed

Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload

Beta-thalassemia | Transfusional Iron Overload

United States, Australia, Thailand
Aptose Biosciences Inc.

Completed

A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer

Pancreatic Cancer
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome

Post COVID-19 Syndrome

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.

Parkinson Disease

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)

System; Lupus Erythematosus

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND for the Treatment of Stroke

Stroke | Stroke, Ischemic

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

United States
Hope Biosciences Stem Cell Research Foundation

No longer available

Individual Patient Expanded Access IND to Treat Polyneuropathy

Polyneuropathies

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Recruiting

Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)

Parkinson Disease

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

"Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis"

Primary Lateral Sclerosis, Adult, 1

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

No longer available

HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.

Congenital Muscular Dystrophy Due to Lamin A/C Mutation

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Active, not recruiting

Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate) (PD)

Parkinson Disease

United States
Avidity Biosciences, Inc.

Not yet recruiting

Phase 3 Global Study of Del-desiran for the Treatment of DM1 (HARBOR)

Myotonic Dystrophy | Myotonic Disorders | Myotonia | Myotonic Dystrophy Type 1 (DM1) | Myotonic Dystrophy 1 | Myotonic Muscular Dystrophy | DM1 | Dystrophy Myotonic | Steinert Disease | Steinert
Modern Biosciences Ltd

Recruiting

Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects

Pharmacokinetics

United Kingdom
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

Chronic Rhinosinusitis With Nasal Polyps

China
Harmony Biosciences, LLC

Recruiting

A Study of Pitolisant in Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Pulse Biosciences, Inc.

Not yet recruiting

CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation

Atrial Fibrillation | Surgery

Netherlands
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis

Atopic Dermatitis

China

Clinical Trials Sponsored by Spruce Biosciences

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations